His comments have stemmed from the press release from Sanofi and Regeneron outlining their extensive Phase 3 program for their novel lipid lowering agent , REGN27, a PCSK9 inhibitor which is the most advanced agent in this highly competitive field.
Mr Berry said a family of four travelling to the US can pay up to three-and-a-half times more for "tied" insurance through a travel agent compared with a more competitive insurer.